To know the analgesic effect of abgel soaked Ropivacaine and with abgel soaked Ropivacaine and dexmedetomidine in spine surgery
Phase 4
- Conditions
- Health Condition 1: O- Medical and SurgicalHealth Condition 2: O- Medical and SurgicalHealth Condition 3: M958- Other specified acquired deformities of musculoskeletal system
- Registration Number
- CTRI/2024/08/072368
- Lead Sponsor
- Rajendra institute of medical sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
ASA grade I or ASA II patient posted for elective spinal surgery
Exclusion Criteria
patient with ASA III or above history of previous spine surgery pre existing neurological psychological cardiorespiratory hepatic renal failure or metabolic disease undergoing cervical level laminectomy accidental dural tear coagulation disorder patient who did not provide their consent history of allergy to Ropivacaine Dexmedetomidine
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate the efficacy of analgesia of gel foam soaked ropivacaine <br/ ><br> To evaluate the efficacy of analgesia of gel foam soaked ropivacaine and dexmedetomidine <br/ ><br>Timepoint: Before closure of skin <br/ ><br>
- Secondary Outcome Measures
Name Time Method evel of sedation among both groups postoperatively. <br/ ><br>side effect like, Bradycardia and hypotension up to 24 hours <br/ ><br>Timepoint: At intervals of 0 1 2 4 8 12 18 and 24 hr